From: Practical aspects of treatment with drotrecogin alfa (activated)
Registry/Trial | Country | Patients treated with DrotAA (% of cases) | ARR | OR (95% CI) |
---|---|---|---|---|
PROWESS | International | 1,690 | 6.1% | 0.8 (0.69 to 0.94) |
 | UK [21] | 1,245 (6.3%) |  | 0.75 (0.68 to 0.83) |
 | Poland [22] | 302 (9.3%) | 17.3% |  |
PROGRESS | International [20] | 882 (7%) | Â | 0.75 (0.63 to 0.9) |
 | Belgium [24] | 430 | 12.8% | 0.61 (0.40 to 0.92) |